Spies; Veronika

Patent Applications and Registrations

Patent applications and USPTO patent grants for Spies; Veronika.The latest application filed is for "methods and compositions for treating autoimmune diseases or conditions".

Company Profile

0.5.16

Spies; Veronika - Seattle WA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
NKG2D decoys Grant 10,815,290 - Gewe , et al. October 27, 2	2020-10-27
Methods And Compositions For Treating Autoimmune Diseases Or Conditions App 20200115459 - Spies; Thomas ; et al.	2020-04-16
Methods and Compositions Involving NKG2D Inhibitors and Cancer App 20190048079 - SPIES; Thomas ; et al.	2019-02-14
Nkg2d Decoys App 20180371051 - Strong; Roland K. ; et al.	2018-12-27
Methods and compositions involving NKG2D inhibitors and cancer Grant 10,040,853 - Spies , et al. August 7, 2	2018-08-07
Methods And Compositions For Treating Autoimmune Diseases Or Conditions App 20150337041 - SPIES; Thomas ; et al.	2015-11-26
Methods and Compositions Involving NKG2D Inhibitors and Cancer App 20140377266 - Spies; Thomas ; et al.	2014-12-25
Methods And Compositions For Treating Autoimmune Diseases Or Conditions App 20130011395 - Spies; Thomas ; et al.	2013-01-10
Soluble Mic Polypeptides As Markers For Diagnosis, Prognosis And Treatment Of Cancer And Autoimmune Diseases Or Conditions App 20100316650 - Spies; Thomas ; et al.	2010-12-16
Soluble MIC polypeptides as markers for diagnosis, prognosis and treatment of cancer and autoimmune diseases or conditions Grant 7,771,718 - Spies , et al. August 10, 2	2010-08-10
Methods and Compositions For Treating Autoimmune Diseases or Conditions App 20100166754 - Spies; Thomas ; et al.	2010-07-01
Methods and compositions for treating autoimmune diseases or conditions Grant 7,666,417 - Spies , et al. February 23, 2	2010-02-23
Negative Immunomodulation Of Immune Responses By Nkg2d-positive Cd4+ Cells App 20070248607 - Spies; Thomas ; et al.	2007-10-25
Activation of Lymphocyte Populations Expressing NKG2D Using Anti-NKG2D Antibodies and Ligand Derivatives App 20070077241 - Spies; Thomas ; et al.	2007-04-05
Soluble mic polypeptides as markers for diagnosis, prognosis and treatment of cancer and autoimmune diseases or conditions App 20050233391 - Spies, Thomas ; et al.	2005-10-20
Methods and compositions for treating autoimmune diseases or conditions App 20050158307 - Spies, Thomas ; et al.	2005-07-21
Activation of lymphocyte populations expressing NKG2D using anti-NKG2D antibodies and ligand derivatives App 20040115198 - Spies, Thomas ; et al.	2004-06-17
Cell stress regulated human MHC class I gene App 20030165835 - Spies, Thomas ; et al.	2003-09-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.